IFNA1 and COVID-19: Data from clinical studies increasingly support a hypothesis that deficiency of initial IFN responses to SARS-CoV-2 may allow for increased viral replication that then supports systemic inflammatory responses that contribute to COVID-19 pathology and severity19,22–24.